CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on January 3, 2007
Clinical Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.2215/CJN.02630706
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.02630706v1
2/2/320    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanchard, A.
Right arrow Articles by Jeunemaitre, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanchard, A.
Right arrow Articles by Jeunemaitre, X.

Received July 27, 2006
Accepted on December 4, 2006

ORIGINAL ARTICLES

Partial Human Genetic Deficiency in Tissue Kallikrein Activity and Renal Calcium Handling

Anne Blanchard *{dagger}{ddagger}1, Michel Azizi {dagger}{sect}||, Séverine Peyrard {sect}, Nora Stern {sect}, François Alhenc-Gelas {ddagger}, Pascal Houillier *{dagger}{ddagger}, and Xavier Jeunemaitre {dagger}¶*

Assistance Publique des Hôpitaux de Paris, Hôpital Européen George Pompidou, *Département de physiologie et radio-isotopes, {sect}Centre d’Investigations Cliniques, and ¶Département de Génétique, {dagger}Université Paris Descartes, Faculté de Médecine, {ddagger}INSERM U652, ||INSERM, CIC 9201, and *INSERM, U772, Paris, France


1 To whom correspondence should be addressed. E-mail: anne.blanchard{at}egp.aphp.fr.


   Abstract

A loss-of-function polymorphism of the human tissue kallikrein (TK) gene (R53H) induces a major decrease in enzyme activity. Inactivation of the TK gene in mice causes a defect in tubular calcium (Ca) reabsorption. Therefore, this study investigated the Ca phenotype of carriers of the 53H allele. In a crossover study, 30 R53R homozygous and 10 R53H heterozygous young white male individuals were randomly assigned to two 7-d low-Ca diets (10 mmol/d) associated with either a low-sodium (Na)/high-potassium (K) diet or a high-Na/low-K diet to modulate TK synthesis. On the seventh day of each diet, the participants were studied before and during a 2-h infusion of furosemide that functionally excludes the thick ascending limb and increases Ca delivery to distal tubular segments. Urinary kallikrein activity was 50 to 60% lower in R53H participants than in R53R participants. Adaptation of urinary Ca excretion to the contrasted Na/K diets was unaffected in R53H participants. By contrast, R53H participants after furosemide infusion had significantly lower serum ionized Ca concentrations than did R53R participants (P < 0.0001) and tendency toward nonsignificantly higher urinary Ca excretions than did R53R participants (P = 0.14). These effects were more marked under low-Na/high-K diet. Despite nonsignificant differences in urinary Ca excretions between the two groups, these results suggest in R53H individuals an increase in Ca reabsorption in the thick ascending limb under baseline conditions that counteracts a distal tubular defect that is revealed by furosemide infusion. In humans as in mice, TK thus may act as an intrarenal modulator of Ca reabsorption.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Nephrology.